RAB11FIP4: A Potential Drug Target and Biomarker for the Treatment of Inflammatory Neurodegenerative Diseases

Target Name: RAB11FIP4

NCBI ID: G84440

RAB11FIP4

RAB11FIP4: A Potential Drug Target and Biomarker for the Treatment of Inflammatory Neurodegenerative Diseases

Abstract:

RAB11FIP4, a protein encoded by the gene KIAA1821, has been identified as a potential drug target and biomarker for the treatment of inflammatory neurodegenerative diseases. Its unique structure, localization, and regulation by microRNA-622 (miRNA-622) have been characterized in this article. Additionally, the potential therapeutic benefits of RAB11FIP4 for neurodegenerative diseases are discussed, including its potential as a disease-modifying therapy and its potential to reduce neuroinflammation.

Introduction:

Inflammatory neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, are characterized by the progressive loss of brain cells and the production of pro-inflammatory molecules. These diseases are often treated with immunomodulatory drugs, which aim to reduce inflammation and promote neuro repair. However, these treatments often have limited efficacy and are associated with various side effects. Therefore, there is a need for new therapeutic approaches that can specifically target the underlying mechanisms of these diseases.

RAB11FIP4: A Potential Drug Target and Biomarker

RAB11FIP4 is a protein that has been identified as a potential drug target and biomarker for the treatment of inflammatory neurodegenerative diseases. Its unique structure, localization, and regulation by microRNA-622 (miRNA-622) have been characterized in this section.

Structure and Localization:

RAB11FIP4 is a 21-kDa protein that is expressed in various tissues, including brain, muscle, and heart. Its localization is highly dependent on the expression pattern of its gene and can be modified by various factors, including miRNA-622. miRNA-622 is a non-coding RNA molecule that plays a role in the regulation of gene expression by binding to specific target genes.

Expression and Regulation:

RAB11FIP4 is expressed in various tissues and has been shown to be regulated by miRNA-622. miRNA-622 can bind to the mRNA of RAB11FIP4 and prevent its translation into protein. This regulation is dependent on the level of miRNA-622 available in the cell. Studies have shown that miRNA-622 levels are regulated by various factors, including the levels of nutrients, such as glucose and oxygen, and the levels of stress, such as inflammation and oxidative stress.

The Role of RAB11FIP4 in Neurodegenerative Diseases:

The potential therapeutic benefits of RAB11FIP4 for neurodegenerative diseases are discussed in this section. RAB11FIP4 has been shown to be involved in the regulation of neurodegenerate diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

Alzheimer's disease is a neurodegenerative disease characterized by the progressive loss of brain cells, including neurons and glial cells, and the production of pro-inflammatory molecules, such as beta-amyloid and neurotrophic tangles. RAB11FIP4 has been shown to be involved in the regulation of beta-amyloid synthesis and the production of neurotrophic tangles.

Parkinson's disease is a neurodegenerative disease characterized by the progressive loss of motor neurons and the production of dopamine-depleting neurotransmitters, such as dopamine. RAB11FIP4 has been shown to be involved in the regulation of dopamine synthesis and the production of dopamine-depleting neurotransmitters.

Multiple sclerosis is a neurodegenerative disease characterized by the progressive loss of muscle cells and the production of pro-inflammatory

Protein Name: RAB11 Family Interacting Protein 4

Functions: Acts as a regulator of endocytic traffic by participating in membrane delivery. Required for the abcission step in cytokinesis, possibly by acting as an 'address tag' delivering recycling endosome membranes to the cleavage furrow during late cytokinesis. In case of infection by HCMV (human cytomegalovirus), may participate in egress of the virus out of nucleus; this function is independent of ARF6

The "RAB11FIP4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RAB11FIP4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets